BioPartner Nordic ApS: Financial statements 2023
CVR: 38153188
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
BioPartner Nordic ApS (CVR 38153188) has filed annual accounts for 2023. In 2023, the company reported revenue of DKK 241,844 and a net result of DKK 94,330 compared with DKK -42,541 the year before. The profit margin was 39%. Equity in the 2023 report amounted to DKK -21,014.
- Revenue
- DKK 241,844
- Gross Profit
- DKK 127,896
- Profit/Loss
- DKK 94,330
- Equity
- DKK -21,014
- Total Assets
- DKK 79,015
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | 242K | 128K | 94K | -21K | - |
| 2022 | - | -13K | -43K | -115K | - |
| 2021 | 121K | 23K | -11K | 5K | - |
| 2020 | 240K | 78K | 56K | -62K | - |
| 2019 | 58K | -137K | -167K | -118K | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
BioPartner Nordic ApS has published its annual report for 2022. Gross profit came to DKK -13,217, and the net result was DKK -42,541.
About BioPartner Nordic ApS
BioPartner Nordic ApS is a Danish company of the type Anpartsselskab based in Hedehusene, founded in 2016. The company is registered under the industry Anden teknisk rådgivning. The management consists of John Holger Schultz. The company is owned by John Holger Schultz. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK -7,778 and a net result of DKK -27,378 compared with DKK -79,721 the year before. Equity in the 2025 report amounted to DKK 22,622.
